EPIX Pharmaceuticals to Participate in Focus Session at the ...
LEXINGTON, Mass.--(BUSINESS WIRE)--May 11, 2007 - EPIX Pharmaceuticals (Nasdaq: EPIX), announced today that Andrew Uprichard, M.D., president and head of research and development of EPIX, will participate in a focus session entitled "The Future of Obesity: Drugs and Devices on the Horizon" at The Neurotech Industry Investing & Partnering Conference at the Westin San Francisco Airport, Millbrae, California, on Friday, May 18, 2007 at 9:15 a.m. (PDT).
Focus sessions are intended to provide investors, executives and leading researchers the opportunity to discuss the development of new drugs, devices and diagnostics for the brain and nervous system, along with corresponding market opportunities. The session will consist of an interactive panel of companies and industry experts, who will discuss the trends, innovations and research developments related to the focus session topic.
No comments:
Post a Comment